ONWARD MEDICAL BV EO -12 (63E) — Cash Flow-to-Debt Ratio
ONWARD MEDICAL BV EO -12 (63E) has a Cash Flow-to-Debt Ratio of -1.34x as of December 2025, meaning its operating cash flow of €-39.07 Million could theoretically repay -1% of its total liabilities (€29.24 Million) in one year. Explore cash efficiency ratio of ONWARD MEDICAL BV EO -12 to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ONWARD MEDICAL BV EO -12 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for ONWARD MEDICAL BV EO -12 across 5 annual periods. Also explore total assets of ONWARD MEDICAL BV EO -12 for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ONWARD MEDICAL BV EO -12 (2021–2025)
Year-by-year debt coverage analysis for ONWARD MEDICAL BV EO -12. For market capitalisation and broader financial context, see 63E stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.34x | €-39.07 Million | €29.24 Million | ▼ -18.1% |
| 2024 | -1.13x | €-31.76 Million | €28.08 Million | ▲ +9.9% |
| 2023 | -1.26x | €-32.27 Million | €25.70 Million | ▼ -12.8% |
| 2022 | -1.11x | €-26.68 Million | €23.96 Million | ▼ -23.9% |
| 2021 | -0.90x | €-19.87 Million | €22.11 Million | — |